Clinical Trial Update: Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) [Phase 2]

View source ↗

Summary

A Phase II trial evaluating preoperative erlotinib (Tarceva) for early non-small cell lung cancer prior to surgery. Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED